Nanogen Reports Rebound with Placement Of Ten NanoChip Stations in Third Quarter | GenomeWeb

Nanogen appears to be rebounding from a rough spell. The company reported ten placements of its flagship product, the NanoChip molecular biology workstation during the third quarter, or triple the number reported in the second quarter.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.